SHROOM4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.769200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.895800E-01
Normal-vs-Stage2
6.603600E-01
Normal-vs-Stage3
8.414000E-01
Normal-vs-Stage4
4.152400E-01
Stage1-vs-Stage2
8.057200E-01
Stage1-vs-Stage3
5.328200E-01
Stage1-vs-Stage4
6.847000E-01
Stage2-vs-Stage3
7.442600E-01
Stage2-vs-Stage4
5.270600E-01
Stage3-vs-Stage4
4.002800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.980000E-01
Normal-vs-AfricanAmerican
2.454600E-01
Normal-vs-Asian
7.945800E-01
Caucasian-vs-AfricanAmerican
1.284630E-01
Caucasian-vs-Asian
2.464200E-01
AfricanAmerican-vs-Asian
4.047500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.034200E-01
Normal-vs-Female
5.458400E-01
Male-vs-Female
1.234640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.782200E-01
Normal-vs-Age(41-60Yrs)
4.502200E-01
Normal-vs-Age(61-80Yrs)
8.009600E-01
Normal-vs-Age(81-100Yrs)
8.990000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.496200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.541200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.018000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.760000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.030370E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.652800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.079600E-01
Normal-vs-Daily Drinker
7.708800E-01
Normal-vs-Weekly Drinker
8.180800E-01
Normal-vs-Occasional Drinker
8.446000E-01
Normal-vs-Social Drinker
6.351600E-01
Non Drinker-vs-Daily Drinker
4.132600E-01
Non Drinker-vs-Weekly Drinker
8.864400E-01
Non Drinker-vs-Occasional Drinker
9.156600E-01
Non Drinker-vs-Social Drinker
3.876600E-01
Daily Drinker-vs-Weekly Drinker
3.421400E-01
Daily Drinker-vs-Occasional Drinker
3.440000E-01
Daily Drinker-vs-Social Drinker
1.907760E-01
Weekly Drinker-vs-Occasional Drinker
9.612000E-01
Weekly Drinker-vs-Social Drinker
4.451000E-01
Occasional Drinker-vs-Social Drinker
4.237200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.983800E-01
Normal-vs-Grade 2
2.701600E-01
Normal-vs-Grade 3
2.814400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.798000E-01
Grade 1-vs-Grade 3
5.403600E-01
Grade 1-vs-Grade 4
3.983800E-01
Grade 2-vs-Grade 3
2.232000E-01
Grade 2-vs-Grade 4
2.701600E-01
Grade 3-vs-Grade 4
2.814400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.727800E-01
Normal-vs-NonDiabetic
8.450800E-01
Diabetic-vs-NonDiabetic
3.926800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.597000E-01
Normal-vs-NoPancreatitis
7.727200E-01
Pancreatitis-vs-NoPancreatitis
8.065800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.503400E-01
Normal-vs-N1
6.221800E-01
N0-vs-N1
2.576000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.396200E-01
Normal-vs-TP53-NonMutant
9.326600E-01
TP53-Mutant-vs-TP53-NonMutant
2.978000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
